Home >> Report Store >> Healthcare >> Global Infection Control Market Size, Analysis Industry Report, 2018-2025 >

Infection Control Market, By Types (Consumable, Equipment, and Services), By End Use (Hospitals, Clinical Laboratories, Healthcare Industries and Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

111 Pages | Published Date : 10 / 12 / 17  | Report Code: AV143 | Report Format: PDF

REPORT HIGHLIGHT

The infection control market is estimated to represent a global market of USD 148.3 billion by 2017 with growth rate of 7.3%.

Market Dynamics

Infection control is associated with the products and technologies that are used to prevent healthcare-associated infections (HAI). HAI is one of the most common complications in clinics and hospital facilities. As per the estimates of the Agency for Healthcare Research and Quality, HAI result more than 1.7 million infections in different healthcare facilities that led to around 99,000 death yearly. Furthermore, the HAI added financial burden of USD 28.0 to USD 33.0 billion every year globally. Numerous government or non-government organizations have started to support projects on HAI preventions owing to the fact that financial burden and number of facilities affected by healthcare infections is increasing continuously. For example, the Agency for Healthcare Research and Quality (AHRQ) implemented the Comprehensive Unit-based Safety Program (CUSP). The program is based on the intensive care unit safety reporting system to address various healthcare-associated infections. These types of initiatives would, in turn, provide a healthy platform for the market development, leading to driving the market growth.

Types Takeaway

Infection control market is categorized as Consumable, Equipment, and Services. Consumables are world’s largest infection control market, capturing approximately 75% share of the market. A substantial share of this segment is attained by the wide usage of these products in different infection control procedures. Consumables segment is categorized as Personal protective equipment (PPE), Disinfectants, Sterilization consumables and Safety enhanced medical devices. In 2016, PPE reached a record high of 15.7 billion and is projected to dominate the market over the forecast period. This equipment includes face shields, respirators, medical gloves, and surgical gowns that provides protection against disease-causing organisms.

Disinfectors and Sterilization Equipment is categorized under equipment. Disinfectors are further divided as Washer, Flusher, and Endoscope Reprocessors. Sterilization equipment is categorized as Heat sterilization equipment, Low-temperature sterilization equipment, Liquid sterilization equipment and Radiation sterilization equipment. Services are divided into Contract sterilization (Eto, E-beam, and gamma sterilization) and Waste disposal. The end-user segment is viewed as Hospitals, Clinical Laboratories, Healthcare Industries and Others. Hospitals and healthcare industries, both led the global market, with each having more than 30% share.

Regional Takeaway

Regionally, North America (especially the U.S. market) hold the first spot in the global infection control market. Increasing demand for infection control products owing to the continuous rise in HAI-related problems drives the market growth. According to the Centers for Disease Control and Prevention (CDC), around 250,000 cases of central line-associated bloodstream infections (CLABSIs) occur in the U.S. hospitals every year. Also, CDC stated that approximately 30,000 to 60,000 patients die every year due to the CLABSIs. Asia Pacific region exhibits fastest growth over the forecast period.

Favorable government initiatives are considered to be the primary driving factor for the market growth. Regulatory policies enforced by healthcare organizations in India and China are favoring higher biosafety to improve the quality of healthcare infrastructure. Organizations such as Asia‐Pacific Biosafety Association trains concerned professionals in the region for biosafety principles and practices. Such parameters will boost the growth of the infection control market in coming years.

Key Vendor Takeaway

Companies such as Getinge Group, Belimed AG, 3M Company, Halyard Health, Inc., and Advanced Sterilization Products are operating in this market. These companies are actively engaged in research and development activities to expand their presence in infection control segment. Due to this, many companies have posted significant revenue from infection control products. For example, as per our estimates, Getinge Group recorded more than USD 700 million from their infection control product sale. Introduction of new products has helped companies to record significant revenue share. For instance, in July 2016, 3M Company introduced biological indicator, featured with four-hour rapid readout for vaporized hydrogen peroxide sterilization. The product is designed to provide results in 4 hours and monitored steam sterilization loads effectively.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

  • Historical Year – 2014 & 2015
  • Base Year – 2015
  • Estimated Year – 2016
  • Projected Year – 2025

TARGET AUDIENCE

  • Traders, Distributors, And Suppliers
  • Manufacturers
  • Hospitals
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPES

  • Consumables
  • Equipment
  • Services

MARKET, BY APPLICATION

  • Hospitals
  • Clinical Laboratories
  • Healthcare Industries
  • Others

MARKET, BY REGION

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America
TABLE OF CONTENT

1. INFECTION CONTROL MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. INFECTION CONTROL KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. INFECTION CONTROL INDUSTRY STUDY
4.1. Company Activity Analysis
4.2. Regulatory Framework Analysis
4.3. Market Attractiveness Analysis
4.4. Value Chain Analysis
5. INFECTION CONTROL MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
6. INFECTION CONTROL MARKET – BY TYPES:
6.1. Overview
6.2. Nucleic Acid Aptamers
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Peptide Aptamers
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. INFECTION CONTROL MARKET – BY APPLICATION:
7.1. Overview
7.2. Therapeutics
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Diagnostics
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Research and Development
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5. Others
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. INFECTION CONTROL MARKET– BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.3. U.S.
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.4. Canada
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.3. France
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.4. Germany
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.5. Rest of Europe
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.3. China
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.4. India
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.5. Rest of APAC
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.3. Latin America
8.5.3.1. Overview
8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.4. Middle East and Africa
8.5.4.1. Overview
8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Opthotech Corporation
9.1.1. Company Overview
9.1.2. SWOT Analysis
9.1.3. Key Developments
9.2. Somalogic, Inc.
9.2.1. Company Overview
9.2.2. SWOT Analysis
9.2.3. Key Developments
9.3. Aptagen
9.3.1. Company Overview
9.3.2. SWOT Analysis
9.3.3. Key Developments
9.4. Aptamer Group
9.4.1. Company Overview
9.4.2. SWOT Analysis
9.4.3. Key Developments
9.5. NOXXON Pharma
9.5.1. Company Overview
9.5.2. SWOT Analysis
9.5.3. Key Developments
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. Abbreviations
11.3. Disclaimer
11.4. Contact Us

List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PESTLE Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Infection Control Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Table 10 Infection Control Market, by Types, 2014 – 2025 (USD Million)
Figure 11 Infection Control Market, by Application, 2014 – 2025 (USD Million)
Figure 12 Infection Control Market, by Geography, 2014 – 2025 (USD Million)
Table 13 North America Infection Control Market, 2014 – 2025 (USD Million)
Table 14 U.S. Infection Control Market, 2014 – 2025 (USD Million)
Table 15 Canada Infection Control Market, 2014 – 2025 (USD Million)
Table 16 Europe Infection Control Market, 2014 – 2025 (USD Million)
Table 17 France Infection Control Market, 2014 – 2025 (USD Million)
Table 18 Germany Infection Control Market, 2014 – 2025 (USD Million)
Table 19 Asia Pacific Infection Control Market, 2014 – 2025 (USD Million)
Table 20 China Infection Control Market, 2014 – 2025 (USD Million)
Table 21 India Infection Control Market, 2014 – 2025 (USD Million)
Table 22 Latin America Infection Control Market, 2014 – 2025 (USD Million)
Table 23 MEA Infection Control Market, 2014 – 2025 (USD Million)

List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Value Chain Analysis Analysis
Figure 6 Infection Control Market, by Types, 2014 – 2025 (USD Million)
Figure 7 Infection Control Market, by Application, 2014 – 2025 (USD Million)
Figure 8 Infection Control Market, by Geography, 2014 – 2025 (USD Million)

SCOPE AND OBJECTIVES :
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT :
• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow

RESEARCH METHDOLOGY

AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:

  • Official Company’s Website, Financial and Annual Reporting
  • Government Statistical Data
  • Online Publishing Articles
  • Industry Player’s Investor Presentations
  • Economic News Articles
  • National and International Trade Associations
  • The Financial, Business and Mainstream Press
  • Industry Study Groups and Other Semi-Official Sources
  • Many Other Informative Channels Related to the Market Topics
  • Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.

MARKET FORECAST

Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.

MARKET ANALYSIS

Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView?

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy And Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This